# Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

> **NCT06157905** · EARLY_PHASE1 · COMPLETED · sponsor: **Services Institute of Medical Sciences, Pakistan** · enrollment: 9 (actual)

## Conditions studied

- Extensive Alopecia Areata

## Interventions

- **DRUG:** Oral Tofacitinib citrate

## Key facts

- **NCT ID:** NCT06157905
- **Lead sponsor:** Services Institute of Medical Sciences, Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-06
- **Primary completion:** 2023-02-05
- **Final completion:** 2023-08-04
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06157905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06157905, "Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06157905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*